Source: CNW Group and Cypress Development.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cypress (CYP) has produced 99.94-per-cent lithium carbonate from lithium-bearing claystone
  • The claystone stems from the company’s 100-per-cent owned Clayton Valley Lithium Project in Nevada
  • The lithium carbonate exceeds standard battery-grade specifications and meets enhanced battery-grade specifications for EV use
  • Cypress Development is an advanced-stage lithium company active in Nevada
  • Cypress (CYP) is up by 25.89 per cent, trading at $1.41 per share

Cypress (CYP) has produced 99.94-per-cent lithium carbonate from lithium-bearing claystone.

The claystone stems from the company’s 100-per-cent owned Clayton Valley Lithium Project in Nevada.

The lithium carbonate – which meets enhanced battery-grade specifications for EV use – was derived from the intermediate concentrated lithium solution produced at Cypress’ lithium extraction facility in Amargosa Valley, Nevada.

Following direct lithium extraction at the facility, Saltworks Technologies completed the processing system design and pilot work to generate the lithium carbonate.

“These are excellent results for the initial iteration of testing and will be incorporated into our ongoing feasibility study on the project,” stated Bill Willoughby, Cypress’ President and CEO. “We are pleased to receive comprehensive assays validating the extraction process we have designed for our project. Exceeding the standard for battery-grade lithium carbonate checks off an important goal for the company and its further development of the project.”

Notes: wt% (weight per cent), Wppm (weight parts per million).

Cypress Development is an advanced-stage lithium company active in Nevada.

Cypress (CYP) is up by 25.89 per cent, trading at $1.41 per share as of 10:17 am EST.


More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.